1-Antitrypsin deficiency * 3: Clinical manifestations and natural history
Open Access
- 1 May 2004
- Vol. 59 (5) , 441-445
- https://doi.org/10.1136/thx.2003.006510
Abstract
A review of the clinical manifestations of α1-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.Keywords
This publication has 69 references indexed in Scilit:
- Efficacy and Safety of Intraoperative Peritoneal Hyperthermic Chemotherapy for Advanced Gastric Cancer Patients with Serosal InvasionDigestive Surgery, 2006
- The Relationship of Chronic Sputum Expectoration to Physiologic, Radiologic, and Health Status Characteristics in α1-Antitrypsin Deficiency (PiZ)Chest, 2002
- Analysis of anti‐neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1‐antitrypsin‐deficient subjectsNephrology Dialysis Transplantation, 2001
- Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)European Respiratory Journal, 1999
- Severe α1-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantationJournal of Hepatology, 1997
- The liver in adolescents with α-antitrypsin deficiencyHepatology, 1995
- Liver disease in alpha-1-antitrypsin deficiency: Prognostic indicatorsThe Journal of Pediatrics, 1990
- Variability of Pulmonary Function in Alpha-1-Antitrypsin Deficiency: Residual Family Resemblance beyond the Effect of the Pi LocusHuman Heredity, 1990
- Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1986
- Alpha1antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type ZRespiratory Medicine, 1983